Urinary symptoms and urodynamic findings in Parkinson's disease;Sintomatología miccional y alteraciones urodinámicas en la enfermedad de Parkinson

Neurologia

Volumn 22, Issue 2, 2007, Pages 93-98

  Barrero Candau, Rafael ^a   Mir, P ^a   Cayuela, A ^a   Campoy, P ^a   Pena, J M ^a   Alberca, R ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Anticholinergic; Incontinence; Parkinson's disease; Urinary symptoms; Urinary urgency; Urodynamic

Indexed keywords

LEVODOPA; TOLTERODINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; OVERACTIVE BLADDER; PARKINSON DISEASE; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION; URODYNAMICS;

AGED; BENZHYDRYL COMPOUNDS; CRESOLS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PARKINSON DISEASE; PHENYLPROPANOLAMINE; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE; URODYNAMICS;

EID: 34147107477     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lemack G, Dewey R, Roherborn CG, O'Suilleabhain PE, Zimmern PE. Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. Urology 2000; 56:250-4.
2. Murnaghan G. Neurogenic disorders of the bladder in parkinsonism. Br J Urol 1961;33:403-9.
3. Berger Y, Blaibas J, Deloracha ER, Salinas JM, Urodynamics findings in Parkinson's disease. J Urol 1987;138:836-8.
4. Martínez-Agulló E, Burguesa J, García-Rebol L, Conejero J, Ruiz JL, Server G, et al. Disfunción del tracto urinario inferior en la enfermedad de Parkinson. Urodinámica Aplicada 1991;3:158-63.
5. Huges AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson'disease. A clinico-pathologycal study of 100 cases. J. Neurol Neurosug Psychiatry 1992;55:181-4.
6. Badia X, García Losa M, Dal-Re R, Carballido J, Serra M. Validation of harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. International Prostate Symptom Score. Urology 1998;52:614-20.
7. Badia X, Castro Díaz D, Perales Cabañas L, Pena Outeriño JM, Martínez Agulló E, Conejero Sugrañes J, et al. Elaboración y validación preliminar del cuestionario para la clasificación clínica de la incontinencia urinaria IU-4. Actas Urol Esp 1999;23:565-72.
8. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmstein U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation subcommitte of the international continence society. Neurourol Urodyn 2002;21:167-78.
9. Van Mastrgt R. Age dependence of urinary bladder contractility (abstract). Neurourol Urodyn 1992;11:315-7.
10. Pavlaquis A, Siroky MB, Goldstein I, Kranner RJ. Neurourological findings in Parkinson's disease. J Urol 1983;129:80-3.
11. Araki I, Kuno S. Assessment of voiding dysfunction in Parkinson's disease by the International Prostate Symptom Score. J Neurol Neurosurg Psychiatry 2000;68:429-33.
12. Defreitas GA, Lemack GE, Zimmer PE, Dewey RB, Roherborn CG, O'Sullibahain. Distinguishing neurogenic from non-neurogenic detrusor overactivity: Aurodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson's disease. Urology 2003;62:651-5.
13. Aranda B, Cramer P. Effect of apomophine and L-dopa on the parkinsonian bladder. Neurourol Urodyn 1993;12:203-9.
14. Koike Y, Takahashi A. Autonomic dysfunction in Parkinson's disease. Eur Neurol 1997;38(Suppl. 2):8-12.
15. Wakabayashi K, Takahashi H. The intermediolateral nucleus and Clarke's column in Parkinson's disease [abstract]. Acta Neuropathol 1997;94:287-9.
16. Lang A, Lozano A. Parkinson's disease. N Engl J Med 1998;339:1044-53.
17. Niimi Y, Ieda T, Hirayama M, Koike Y, Sobue G, Hasegawa Y, et al. Clinical and physiological characteristics of autonomic failure with Parkinson's disease. Clin Auton Res 1999;9:139-44.
18. Micieli G, Tosi P, Marcheselli S, Cavalilli A. Autonomic dys function in Parkinson's disease. Neurol Sci 2003;24(Suppl. 1):32-4.
19. Hobson P, Islam W, Roberts S, Adhiyman V, Meara J. The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls. Parkinsonism Relat Disord 2003;10:67-71.
20. Lewin RV, Dillard GV, Porter RW. Extrapiramidal inhibition of the urinary bladder. Brain Res 1967;4:301-7.
21. Porter RW, Bros E. Neurogenic bladder in parkinsonism: effect of thalamotomy. J Neurosurg 1971;34:27-32.
22. nd International Consultation on Incontinence 2002;9:479-512.
23. Finazzi-Agro E, Peppe A, D'Amico A, Petta F, Mazzone P, Stanzione P, et al. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease. J Urol 2003;169:1388-91.
24. Seif C, Herzog J, van der Horst C, Schrader B, Volkmann J, Deuschl G, et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol 2004;55:118-20.
25. Winge K, Werdelin LM, Nielsen KK, Stimpel H. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Neurourol Urodyn 2004;23:689-96.
26. Bennett N, O'Leary M, Patel AS, Xavier M, Erickson JR, Chancellor MB. Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol 2004;171:749-51.